These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 10355743)

  • 1. Differential distribution of protein phosphatase 2A in human breast carcinoma cell lines and its relation to estrogen receptor status.
    Gopalakrishna R; Gundimeda U; Fontana JA; Clarke R
    Cancer Lett; 1999 Mar; 136(2):143-51. PubMed ID: 10355743
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Models of estrogen receptor regulation by estrogens and antiestrogens in breast cancer cell lines.
    Pink JJ; Jordan VC
    Cancer Res; 1996 May; 56(10):2321-30. PubMed ID: 8625307
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estrogen-dependent rapid activation of protein kinase C in estrogen receptor-positive MCF-7 breast cancer cells and estrogen receptor-negative HCC38 cells is membrane-mediated and inhibited by tamoxifen.
    Boyan BD; Sylvia VL; Frambach T; Lohmann CH; Dietl J; Dean DD; Schwartz Z
    Endocrinology; 2003 May; 144(5):1812-24. PubMed ID: 12697687
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression and regulation of estrogen receptor beta in human breast tumors and cell lines.
    Vladusic EA; Hornby AE; Guerra-Vladusic FK; Lakins J; Lupu R
    Oncol Rep; 2000; 7(1):157-67. PubMed ID: 10601611
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stable transfection of protein kinase C alpha cDNA in hormone-dependent breast cancer cell lines.
    Tonetti DA; Chisamore MJ; Grdina W; Schurz H; Jordan VC
    Br J Cancer; 2000 Sep; 83(6):782-91. PubMed ID: 10952784
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estrogen inhibits the growth of estrogen receptor-negative, but not estrogen receptor-positive, human mammary epithelial cells expressing a recombinant estrogen receptor.
    Zajchowski DA; Sager R; Webster L
    Cancer Res; 1993 Oct; 53(20):5004-11. PubMed ID: 8402691
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of CYP1A1 and CYP1B1 depends on cell-specific factors in human breast cancer cell lines: role of estrogen receptor status.
    Angus WG; Larsen MC; Jefcoate CR
    Carcinogenesis; 1999 Jun; 20(6):947-55. PubMed ID: 10357772
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estrogen-dependent and independent activation of the P1 promoter of the p53 gene in transiently transfected breast cancer cells.
    Hurd C; Dinda S; Khattree N; Moudgil VK
    Oncogene; 1999 Jan; 18(4):1067-72. PubMed ID: 10023683
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of aromatase (CYP19) expression in breast cancer cells through a nongenomic action of estrogen receptor alpha.
    Kinoshita Y; Chen S
    Cancer Res; 2003 Jul; 63(13):3546-55. PubMed ID: 12839940
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential insulin-like growth factor I receptor signaling and function in estrogen receptor (ER)-positive MCF-7 and ER-negative MDA-MB-231 breast cancer cells.
    Bartucci M; Morelli C; Mauro L; Andò S; Surmacz E
    Cancer Res; 2001 Sep; 61(18):6747-54. PubMed ID: 11559546
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protein kinase C and its isoforms in human breast cancer cells: relationship to the invasive phenotype.
    Morse-Gaudio M; Connolly JM; Rose DP
    Int J Oncol; 1998 Jun; 12(6):1349-54. PubMed ID: 9592198
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 17 beta-estradiol-regulated expression of protein tyrosine phosphatase gamma gene in cultured human normal breast and breast cancer cells.
    Zheng J; Kulp SK; Zhang Y; Sugimoto Y; Dayton MA; Govindan MV; Brueggemeier RW; Lin YC
    Anticancer Res; 2000; 20(1A):11-9. PubMed ID: 10769629
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel antitumor effect of estradiol in athymic mice injected with a T47D breast cancer cell line overexpressing protein kinase Calpha.
    Chisamore MJ; Ahmed Y; Bentrem DJ; Jordan VC; Tonetti DA
    Clin Cancer Res; 2001 Oct; 7(10):3156-65. PubMed ID: 11595710
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A metastatic breast tumor cell line, GI-101A, is estrogen receptor positive and responsive to estrogen but resistant to tamoxifen.
    Morrissey JJ; Raney S
    Cell Biol Int; 1998; 22(6):413-9. PubMed ID: 10328849
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endogenous protein kinase-C activation in osteoblast-like cells modulates responsiveness to estrogen and estrogen receptor levels.
    Migliaccio S; Wetsel WC; Fox WM; Washburn TF; Korach KS
    Mol Endocrinol; 1993 Sep; 7(9):1133-43. PubMed ID: 8247015
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stimulation of c-myc oncogene expression associated with estrogen-induced proliferation of human breast cancer cells.
    Dubik D; Dembinski TC; Shiu RP
    Cancer Res; 1987 Dec; 47(24 Pt 1):6517-21. PubMed ID: 3677090
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Breast cancer cell invasiveness: correlation with protein kinase C activity and differential regulation by phorbol ester in estrogen receptor-positive and -negative cells.
    Platet N; Prévostel C; Derocq D; Joubert D; Rochefort H; Garcia M
    Int J Cancer; 1998 Mar; 75(5):750-6. PubMed ID: 9495244
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of estradiol on estrogen receptor-alpha gene expression and activity can be modulated by the ErbB2/PI 3-K/Akt pathway.
    Stoica GE; Franke TF; Moroni M; Mueller S; Morgan E; Iann MC; Winder AD; Reiter R; Wellstein A; Martin MB; Stoica A
    Oncogene; 2003 Sep; 22(39):7998-8011. PubMed ID: 12970748
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A role for protein kinase C delta in the differential sensitivity of MCF-7 and MDA-MB 231 human breast cancer cells to phorbol ester-induced growth arrest and p21(WAFI/CIP1) induction.
    Shanmugam M; Krett NL; Maizels ET; Murad FM; Rosen ST; Hunzicker-Dunn M
    Cancer Lett; 2001 Oct; 172(1):43-53. PubMed ID: 11595128
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Additive growth inhibitory effects of ibandronate and antiestrogens in estrogen receptor-positive breast cancer cell lines.
    Journe F; Chaboteaux C; Magne N; Duvillier H; Laurent G; Body JJ
    Breast Cancer Res; 2006; 8(1):R2. PubMed ID: 16417650
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.